Citurgia Biochemicals Ltd

Citurgia Biochemicals Ltd has announced that its Board of Directors will convene on November 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The trading window for company shares, which was closed from July 1, 2026, will reopen 48 hours after the results are declared.

Citurgia Biochemicals Ltd has received approval from the Registrar of Companies (ROC), Mumbai, for a three-month extension to convene its 51st Annual General Meeting (AGM). The extension allows the company to hold its AGM on or before December 31, 2026, for the financial year ended March 31, 2026. The company had applied for this extension due to circumstances preventing timely convening of the AGM. The ROC granted the extension on November 4, 2026. The specific date for the AGM will be communicated later.

Citurgia Biochemicals Limited announced that its Board of Directors has resolved to apply to the Registrar of Companies (ROC), Mumbai, for a further two-month extension to convene its 51st Annual General Meeting (AGM). The company had previously received a one-month extension until October 31, 2026, for the financial year ended March 31, 2026. The delay is attributed to recent re-listing on BSE, increased post-listing compliances, and a temporary vacancy in the Company Secretary position. The Board meeting was held on October 6, 2026.

Citurgia Biochemicals Ltd has announced a Board of Directors meeting scheduled for October 6, 2026. The primary agenda items include finalizing the date, time, and venue for the 51st Annual General Meeting (AGM) for the Financial Year 2025-2026. The board will also consider and approve the Notice of the 51st AGM, the Director's Report with annexures, and decide on the book closure period for the AGM. This meeting is being held in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Citurgia Biochemicals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 01, 2026, and will reopen 48 hours after the declaration of the Unaudited Standalone & Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The date for the board meeting to approve these financial results will be communicated separately.

Citurgia Biochemicals Ltd has provided an explanation to the stock exchange regarding a delay in disclosing a material event. The event occurred on August 31, 2026, and the disclosure was due within 24 hours. The company cited internal communication delays and the process of obtaining confirmation from authorities, specifically the Registrar of Companies (ROC) Mumbai. The ROC granted an extension of one month on September 18, 2026, allowing the company to hold its AGM by October 31, 2026, for the financial year ended March 31, 2026. Citurgia Biochemicals has strengthened its internal compliance mechanisms to prevent future delays and regrets the inadvertent oversight.

Citurgia Biochemicals Ltd has received approval from the Registrar of Companies (ROC), Mumbai, for a one-month extension to convene its 51st Annual General Meeting (AGM). The company had initially sought a three-month extension to hold the AGM for the financial year ended March 31, 2026, by December 31, 2025. The ROC, in its letter dated September 18, 2026, granted an extension of one month, allowing the AGM to be held on or before October 31, 2026. The company will announce the final AGM date in due course.

Citurgia Biochemicals Ltd has reported its unaudited financial results for the quarter ended June 30, 2026. The company posted a net loss of ₹8.20 Lakhs for the quarter, compared to a loss of ₹8.39 Lakhs in the corresponding quarter of the previous year. Total expenses for the quarter stood at ₹8.20 Lakhs. Earnings per share (EPS) for the period was reported as ₹0.000 on a basic and diluted basis. The results were approved by the Board of Directors on August 12, 2026, and were accompanied by a limited review report from the statutory auditor.

Citurgia Biochemicals Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. The trading window for company shares, which closed on July 1, 2026, will reopen 48 hours after the results are declared.

Citurgia Biochemicals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in accordance with SEBI (LODR) Regulations, 2015 and the company's internal code of conduct for preventing insider trading. The trading window will remain shut from July 1st, 2026, until two calendar days after the board meeting where the un-audited financial results for the quarter ending June 30th, 2026, will be declared. This measure is standard practice to ensure fair disclosure and prevent potential insider trading ahead of financial result announcements.